Revenue
attach_money29,641M JPY
YoY +2.8%
SOLTFNxera Pharma Co., Ltd.$ --
Nxera Pharma Co., Ltd.
SOLTF
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-8,281M JPY
YoY -52.7%
Net Income
verified-12,541M JPY
YoY -159.2%
EPS
pie_chart-139.6JPY
YoY -158.8%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress1575.4%On Track
Revenue Progress29.7B
Revenue Forecast32.8B
Net Income Progress-12.6B
Net Income Forecast-797.3M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.